Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Truntzer

Showing results (71-80 of 104) with videos related to

Pageof 11
Sort By:
Gut|July 13, 2021
<i>Helicobacter pylori</i> infection has a detrimental impact on the efficacy of cancer immunotherapiesPaul Oster, Laurie Vaillant, Erika Riva, et al.
International Journal of Molecular Medicine|March 4, 2022
Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical useSandy Chevrier, Astrid Brasselet, Marion Carnet, et al.
Nature Immunology|February 1, 2022
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responsesMélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registrySylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
Plos One|April 9, 2013
An improved method to extract DNA from 1 ml of uncultured amniotic fluid from patients at less than 16 weeks' gestationAnne-Laure Mosca-Boidron, Laurence Faivre, Serge Aho, et al.
NPJ Breast Cancer|March 5, 2022
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencingLoïck Galland, Elise Ballot, Hugo Mananet, et al.
Blood|October 30, 2009
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemiaNathalie Droin, Arnaud Jacquel, Jean-Baptiste Hendra, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacyJulie Niogret, Hélène Berger, Cédric Rebe, et al.
The Journal of Clinical Investigation|July 1, 2025
Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doubletLaura Kalfeist, Fanny Ledys, Stacy Petit, et al.
Cancers|June 28, 2023
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSCNesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, et al.
Pageof 11

Showing results (71-80 of 104) with videos related to

Sort By:
Pageof 11
Gut|July 13, 2021
<i>Helicobacter pylori</i> infection has a detrimental impact on the efficacy of cancer immunotherapiesPaul Oster, Laurie Vaillant, Erika Riva, et al.
International Journal of Molecular Medicine|March 4, 2022
Custom multi‑tumor next‑generation sequencing panel for routine molecular diagnosis of solid tumors: Validation and results from three‑year clinical useSandy Chevrier, Astrid Brasselet, Marion Carnet, et al.
Nature Immunology|February 1, 2022
Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responsesMélanie Bruchard, Mannon Geindreau, Anaïs Perrichet, et al.
Breast (Edinburgh, Scotland)|September 7, 2024
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registrySylvain Ladoire, Ariane Mamguem Kamga, Loick Galland, et al.
Plos One|April 9, 2013
An improved method to extract DNA from 1 ml of uncultured amniotic fluid from patients at less than 16 weeks' gestationAnne-Laure Mosca-Boidron, Laurence Faivre, Serge Aho, et al.
NPJ Breast Cancer|March 5, 2022
Efficacy of platinum-based chemotherapy in metastatic breast cancer and HRD biomarkers: utility of exome sequencingLoïck Galland, Elise Ballot, Hugo Mananet, et al.
Blood|October 30, 2009
Alpha-defensins secreted by dysplastic granulocytes inhibit the differentiation of monocytes in chronic myelomonocytic leukemiaNathalie Droin, Arnaud Jacquel, Jean-Baptiste Hendra, et al.
Journal for Immunotherapy of Cancer|June 9, 2021
Follicular helper-T cells restore CD8<sup>+</sup>-dependent antitumor immunity and anti-PD-L1/PD-1 efficacyJulie Niogret, Hélène Berger, Cédric Rebe, et al.
The Journal of Clinical Investigation|July 1, 2025
Co-targeting TGF-β and PD-L1 sensitizes triple-negative breast cancer to experimental immunogenic cisplatin-eribulin chemotherapy doubletLaura Kalfeist, Fanny Ledys, Stacy Petit, et al.
Cancers|June 28, 2023
GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSCNesrine Mabrouk, Cindy Racoeur, Jingxuan Shan, et al.
Pageof 11